Results 151 to 160 of about 29,724,597 (193)

Old dog, new trick: Charybdotoxin as a novel ryanodine receptor blocker

open access: yesThe Journal of Physiology, Volume 604, Issue 17, Page 7246-7263, 1 September 2026.
Abstract figure legend The peptide toxin charybdotoxin (ChTx) from the scorpion Leiurus quinquestriatus was tested on single‐channel currents of the ryanodine receptor incorporated into planar lipid bilayers. The structure–function relationship of ChTx was investigated using toxin variants generated by isosteric substitutions of the basic amino acids ...
Zsuzsanna Édua Magyar   +10 more
wiley   +1 more source

Long‐term imoxin treatment does not attenuate disease severity in dystrophic diaphragm of male mice

open access: yesPhysiological Reports, Volume 14, Issue 18, September 2026.
Abstract Duchenne muscular dystrophy (DMD) is characterized by chronic skeletal muscle injury and degeneration. We discovered activation of protein kinase R (PKR; EIF2AK2), a regulator of the integrated stress response, in dystrophic muscle; however, its role in DMD remains unknown.
Ji Heun Lee   +4 more
wiley   +1 more source

NMDA receptor antagonists reduce amyloid-β deposition by modulating calpain-1 signaling and autophagy, rescuing cognitive impairment in 5XFAD mice. [PDF]

open access: yesCell Mol Life Sci, 2022
Companys-Alemany J   +6 more
europepmc   +1 more source

Targeting Calpain-1 and Calpain-2 for Prevention of Breast Cancer Metastasis: In Vivo Insights and Drug Discovery Approaches [PDF]

open access: yes
Due to breast cancer’s aggressive behavior and lack of effective targeted therapies once it becomes metastatic, it remains a leading cause of cancer mortality among women.
Shapovalov, Ivan
core  

Home - About - Disclaimer - Privacy